<!DOCTYPE html>
<html lang="en-US"><head>
		<meta charset="UTF-8">
		<title>FT934-10862</title>
	</head>
	<body>
		<main>
			<p>931103 FT  03 NOV 93 / International Company News: Merck drug withdrawn MERCK yesterday withdrew Roxiam, a schizophrenia treatment which was awaiting approval from the US Food and Drug Administration. The move follows the death of a patient in Europe, write Richard Waters and Paul Abrahams in New York. The drug, which has been marketed in Europe by Astra, the Swedish company, for the past two and a half years, was said by analysts to have the potential for peak annual sales of Dollars 100m-Dollars 250m in the US. The withdrawal followed the development of a blood disorder in eight patients taking the drug in Europe.</p>
		</main>
</body></html>
            